Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Anuh Pharma Ltd.
Swot
Anuh Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Anuh Pharma Ltd. has 14 Strengths, 11 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(11)
Opportunity
(0)
Threats
(1)
Others
(3)
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Consistent Highest Return Stocks over Five Years - Nifty500
Mid-range Performer (DVM)
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Degrowth in Revenue and Profit
Fall in Quarterly Revenue and Net Profit (YoY)
Near 52 Week Low
Weak Momentum: Price below Short, Medium and Long Term Averages
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
RSI indicating price weakness
Top Losers
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter
Insiders sold stocks
Stocks with improving cash flow, with good durability
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)